Most Recent
AMP has agreed to pay $29 million to settle a class action alleging insurance customers were overcharged, putting to rest another case stemming from "serious misconduct" that came to light curing the 2018 banking royal commission.
The High Court has unanimously granted home retailer Bed Bath N’ Table’s appeal of a ruling that retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.
A judge has found the ATO knowingly received millions misappropriated by a former Kupang Resources director in order to satisfy a tax debt against him, with a judge skewering the tax office for instituting a “policy of wilful blindness” in pursuit of the debt.
ASIC has sued superannuation trustee Diversa for investing $300 million in retirement savings into Falcon Capital's failed First Guardian Master fund.
Construction PRO
Ramsay Health Care has lost its challenge to development approval for a community health care services centre near its Greenslopes Hospital in Brisbane, with a court finding the centre would not interfere with the hospital’s operations.
Construction PRO
Snowy Hydro has been joined to former senator and self-styled 'transparency warrior' Rex Patrick's case seeking documents on the $12 billion Snowy 2.0 renewables project.
Collapsed supply chain finance company Greensill Bank can't access a copy of a Tokio Marine unit's database, with a judge finding the copy was created for the primary purpose of HWL Ebsworth providing legal advice.
Construction PRO
A community group has lost a legal challenge to a 50-60 km underground pipeline that will connect Santos’ $3.6 billion Narrabri gas project to the Hunter gas pipeline.
A SkyCity shareholder has lost his bid to bring a case against former executives and directors at the ASX-listed casino seeking to recoup a $67 million penalty over breaches of money laundering regulations.
Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno's generic version of schizophrenia drug Invega Sustenna.